226 related articles for article (PubMed ID: 33371906)
1. Integrative analysis of histopathological images and chromatin accessibility data for estrogen receptor-positive breast cancer.
Xu S; Lu Z; Shao W; Yu CY; Reiter JL; Feng Q; Feng W; Huang K; Liu Y
BMC Med Genomics; 2020 Dec; 13(Suppl 11):195. PubMed ID: 33371906
[TBL] [Abstract][Full Text] [Related]
2. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
[TBL] [Abstract][Full Text] [Related]
3. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells.
Lin CY; Ström A; Vega VB; Kong SL; Yeo AL; Thomsen JS; Chan WC; Doray B; Bangarusamy DK; Ramasamy A; Vergara LA; Tang S; Chong A; Bajic VB; Miller LD; Gustafsson JA; Liu ET
Genome Biol; 2004; 5(9):R66. PubMed ID: 15345050
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
6. ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
Lin CL; Tan X; Chen M; Kusi M; Hung CN; Chou CW; Hsu YT; Wang CM; Kirma N; Chen CL; Lin CH; Lathrop KI; Elledge R; Kaklamani VG; Mitsuya K; Huang TH
BMC Med Genomics; 2020 May; 13(1):69. PubMed ID: 32408897
[TBL] [Abstract][Full Text] [Related]
7. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
8. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
[TBL] [Abstract][Full Text] [Related]
9. regSNPs-ASB: A Computational Framework for Identifying Allele-Specific Transcription Factor Binding From ATAC-seq Data.
Xu S; Feng W; Lu Z; Yu CY; Shao W; Nakshatri H; Reiter JL; Gao H; Chu X; Wang Y; Liu Y
Front Bioeng Biotechnol; 2020; 8():886. PubMed ID: 32850739
[TBL] [Abstract][Full Text] [Related]
10. Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers.
Osmanbeyoglu HU; Shimizu F; Rynne-Vidal A; Alonso-Curbelo D; Chen HA; Wen HY; Yeung TL; Jelinic P; Razavi P; Lowe SW; Mok SC; Chiosis G; Levine DA; Leslie CS
Nat Commun; 2019 Sep; 10(1):4369. PubMed ID: 31554806
[TBL] [Abstract][Full Text] [Related]
11. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
12. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
13. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
14. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
15. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
[TBL] [Abstract][Full Text] [Related]
16. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.
Gu F; Hsu HK; Hsu PY; Wu J; Ma Y; Parvin J; Huang TH; Jin VX
BMC Syst Biol; 2010 Dec; 4():170. PubMed ID: 21167036
[TBL] [Abstract][Full Text] [Related]
17. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
18. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.
Wang Y; Hao DP; Li JJ; Wang L; Di LJ
Oncotarget; 2017 Jul; 8(27):44705-44719. PubMed ID: 28621677
[TBL] [Abstract][Full Text] [Related]
20. Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns.
Ugalde-Morales E; Grassmann F; Humphreys K; Li J; Eriksson M; Tobin NP; Borg Å; Vallon-Christersson J; Hall P; Czene K
Int J Cancer; 2021 Feb; 148(4):884-894. PubMed ID: 32856720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
